Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - NET CHANGE IN CASH
Net Change in Cash AKBA - Akebia Therapeutics, Inc.
-48.6 M
LAST VALUE
21.72%
2 YEAR CAGR
-18.76%
5 YEAR CAGR
-13.29%
10 YEAR CAGR